592 related articles for article (PubMed ID: 30564887)
21. Synthesis, characterization and irradiation enhances anticancer activity of liposome-loaded iridium(III) complexes.
Tian S; Nie Q; Chen H; Liang L; Hu H; Tang S; Yang J; Liu Y; Yin H
J Inorg Biochem; 2024 Jul; 256():112549. PubMed ID: 38579631
[TBL] [Abstract][Full Text] [Related]
22. Increasing anticancer effect in vitro and vivo of liposome-encapsulated iridium(III) complexes on BEL-7402 cells.
Zhang Y; Fei W; Zhang H; Zhou Y; Tian L; Hao J; Yuan Y; Li W; Liu Y
J Inorg Biochem; 2021 Dec; 225():111622. PubMed ID: 34624670
[TBL] [Abstract][Full Text] [Related]
23. DNA binding and evaluation of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes.
Zhang Y; Zhou Y; Zhang H; Tian L; Hao J; Yuan Y; Li W; Liu Y
J Inorg Biochem; 2021 Nov; 224():111580. PubMed ID: 34438219
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, DNA binding, antibacterial and anticancer properties of two novel water-soluble copper(II) complexes containing gluconate.
Cai DH; Zhang CL; Liu QY; He L; Liu YJ; Xiong YH; Le XY
Eur J Med Chem; 2021 Mar; 213():113182. PubMed ID: 33486198
[TBL] [Abstract][Full Text] [Related]
25. Enhanced in vitro cytotoxicity and antitumor activity in vivo of iridium(III) complexes liposomes targeting endoplasmic reticulum and mitochondria.
Li W; Wu X; Liu H; Shi C; Yuan Y; Bai L; Liao X; Zhang Y; Liu Y
J Inorg Biochem; 2022 Aug; 233():111868. PubMed ID: 35636300
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, Characterization and Anticancer Efficacy Studies of Iridium (III) Polypyridyl Complexes against Colon Cancer HCT116 Cells.
Xie B; Wang Y; Wang D; Xue X; Nie Y
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080200
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and evaluation of iridium(III) complexes on antineoplastic activity against human gastric carcinoma SGC-7901 cells.
Tian L; Zhang Y; Zhang H; Zhou Y; Li W; Yuan Y; Hao J; Yang L; Liu Y
J Biol Inorg Chem; 2021 Sep; 26(6):705-714. PubMed ID: 34448071
[TBL] [Abstract][Full Text] [Related]
28. Iridium (III) complexes induce cervical carcinoma apoptosis via disturbing cellular redox homeostasis disorder and inhibiting PI3K/AKT/mTOR pathway.
Hao J; Liu H; Wang J; Wang X; Huang C; Liang L; Chen J; Wang Y; Liu Y
J Inorg Biochem; 2022 Oct; 235():111946. PubMed ID: 35932758
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and biological evaluation of liposome entrapped iridium(III) complexes toward SGC-7901 cells.
Chen Y; Gu Y; Hu H; Liu H; Li W; Huang C; Chen J; Liang L; Liu Y
J Inorg Biochem; 2023 Apr; 241():112134. PubMed ID: 36706490
[TBL] [Abstract][Full Text] [Related]
30. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z
Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192
[TBL] [Abstract][Full Text] [Related]
31. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
[TBL] [Abstract][Full Text] [Related]
32. Iridium(III) complexes inhibit the proliferation and migration of BEL-7402 cells through the PI3K/AKT/mTOR signaling pathway.
Chen J; Liu H; Chen Y; Hu H; Huang C; Wang Y; Liang L; Liu Y
J Inorg Biochem; 2023 Apr; 241():112145. PubMed ID: 36709684
[TBL] [Abstract][Full Text] [Related]
33. Triphenylamine-appended cyclometallated iridium(III) complexes: Preparation, photophysical properties and application in biology/luminescence imaging.
Liu X; Hao H; Ge X; He X; Liu Y; Wang Y; Wang H; Shao M; Jing Z; Tian L; Liu Z
J Inorg Biochem; 2019 Oct; 199():110757. PubMed ID: 31445461
[TBL] [Abstract][Full Text] [Related]
34. New iridium bis-terpyridine complexes: synthesis, characterization, antibiofilm and anticancer potentials.
Sahin C; Mutlu D; Nasirli F; Mahmoudi G; Zubkov FI; Arslan S; Dogan NM
Biometals; 2021 Jun; 34(3):701-713. PubMed ID: 33900533
[TBL] [Abstract][Full Text] [Related]
35. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents.
Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z
Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276
[TBL] [Abstract][Full Text] [Related]
36. Mitochondria-targeted iridium(III) complexes encapsulated in liposome induce cell death through ferroptosis and gasdermin-mediated pyroptosis.
Huang C; Yuan Y; Li G; Tian S; Hu H; Chen J; Liang L; Wang Y; Liu Y
Eur J Med Chem; 2024 Feb; 265():116112. PubMed ID: 38183779
[TBL] [Abstract][Full Text] [Related]
37. Exploring anticancer efficiency of mitochondria-targeted cyclometalated iridium(III) complexes.
Gu Y; Wen H; Bai L; Zhou Y; Zhang H; Tian L; Zhang Y; Hao J; Liu Y
J Inorg Biochem; 2020 Nov; 212():111215. PubMed ID: 32919250
[TBL] [Abstract][Full Text] [Related]
38. Studies of anticancer activity in vivo and in vitro behaviors of liposomes encapsulated iridium(III) complex.
Gu Y; Wen H; Zhang Y; Bai L; Zhou Y; Zhang H; Tian L; Hao J; Liu Y
J Biol Inorg Chem; 2021 Feb; 26(1):109-122. PubMed ID: 33475857
[TBL] [Abstract][Full Text] [Related]
39. Anticancer mechanism studies of iridium(III) complexes inhibiting osteosarcoma HOS cells proliferation.
Xie FL; Wang Y; Zhu JW; Xu HH; Guo QF; Wu Y; Liu SH
J Inorg Biochem; 2022 Dec; 237():112011. PubMed ID: 36252336
[TBL] [Abstract][Full Text] [Related]
40. Mitochondria-targeted cyclometalated iridium (III) complexes: Dual induction of A549 cells apoptosis and autophagy.
Chen L; Tang H; Chen W; Wang J; Zhang S; Gao J; Chen Y; Zhu X; Huang Z; Chen J
J Inorg Biochem; 2023 Dec; 249():112397. PubMed ID: 37844533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]